The trademark application EKORTSYM was filed by AstraZeneca AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on June 20, 2022, and it was registered by office on September 27, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).